Related Experiment Video
Updated: May 22, 2026

Erythrocyte Sedimentation Rate: A Physics-Driven Characterization in a Medical Context
Published on: March 24, 2023
Erythrocyte sedimentation rate as a marker for coronary heart disease
1Department of Internal Medicine, Vinzentius Hospital, Landau, Germany. josef.yayan@hotmail.com
Insights
The erythrocyte sedimentation rate (ESR) may help identify coronary heart disease in patients lacking typical cardiac markers. A prolonged ESR was observed in over half of patients with coronary heart disease, suggesting its utility as an additional diagnostic indicator.
Area of Science:
- Cardiology
- Clinical Pathology
Background:
- Patients with angina pectoris or myocardial infarction often lack definitive cardiac enzyme or ECG evidence.
- Early identification is crucial for timely treatment of acute coronary heart disease.
Purpose of the Study:
- To evaluate the erythrocyte sedimentation rate (ESR) as a potential additional indicator for coronary heart disease (CHD).
- To facilitate quicker identification and treatment of patients with angina pectoris or myocardial infarction.
Main Methods:
- Included patients diagnosed with angina pectoris or myocardial infarction via heart catheterization and coronary angiography.
- Excluded patients with inflammatory or tumor diseases.
- Measured erythrocyte sedimentation rate in all participants, including a control group without CHD.
Main Results:
- A prolonged erythrocyte sedimentation rate was found in 58.09% of patients.
- 50.74% of patients with confirmed coronary heart disease had a prolonged ESR.
- The specificity and sensitivity of ESR for coronary heart disease were 70.59% and 67.65%, respectively.
Conclusions:
- Erythrocyte sedimentation rate may serve as a valuable supplementary diagnostic criterion for coronary heart disease.
- ESR's utility warrants further investigation in clinical settings for early CHD detection.
Background:
Patients with angina pectoris or myocardial infarction frequently present without evidence of cardiac-specific heart enzymes by laboratory analysis or specific pathologic electro-cardiogram findings. The current study analyzed the efficacy of the erythrocyte sedimentation rate as an additional potential indicator for coronary heart disease, the aim being to enable quicker identification of patients with angina pectoris or myocardial infarction so that they can be more rapidly treated.
Methods:
Patients with angina pectoris or myocardial infarction who had undergone a heart catheter examination were included in the study. The diagnosis of acute coronary heart disease was made by the physician who performed coronary angiography. Patients without coronary heart disease were used as a control group. The erythrocyte sedimentation rate was measured in all patients. Patients with angina pectoris or myocardial infarction and an inflammatory or tumor disease were excluded.
Results:
The erythrocyte sedimentation rate was prolonged in 79 (58.09%) of 136 patients; 69 (50.74%) patients (95% confidence interval ±8.4%, 42.34%-59.14%) had coronary heart disease and a prolonged erythrocyte sedimentation rate. The erythrocyte sedimentation rate was prolonged in ten (7.35%) patients (95% confidence interval ±4.39%, 2.96%-11.74%) without coronary heart disease by coronary angiography. The specificity of the erythrocyte sedimentation rate for coronary heart disease was 70.59% and the sensitivity was 67.65%.
Conclusion:
Erythrocyte sedimentation rate may be a useful additional diagnostic criterion for coronary heart disease.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Rheumatic Heart Disease I: Introduction
